West Pharma (WST) Tops Q2 EPS by 5c
Tweet
Share
E-mailGet Alerts WST Hot Sheet
Price: $373.85 +3.34%
Revenue Growth %: +2.6%
Financial Fact:
Gross profit: 121.1M
Today's EPS Names:
OCCI, ALZN, ASPU, More
Revenue Growth %: +2.6%
Financial Fact:
Gross profit: 121.1M
Today's EPS Names:
OCCI, ALZN, ASPU, More
Join SI Premium – FREE
West Pharmaceutical Services, Inc. (NYSE: WST) reported Q2 EPS of $0.52, $0.05 better than the analyst estimate of $0.47. Revenue for the quarter came in at $368.9 million versus the consensus estimate of $368.6 million.
West Pharmaceutical Services, Inc. reaffirmed FY2014 guidance.
For earnings history and earnings-related data on West Pharmaceutical Services, Inc. (WST) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- MillerKnoll, Inc. (MLKN) Tops Q1 EPS by 18c ; Offers Guidance
- UBS Reiterates Buy Rating on Option Care Health (OPCH) Following Check-in Call Ahead of Quiet Period
- Goldman: 'Our key conclusion is that AI is likely to be credit-positive for banks', 'Rearming Our Overweight Stance on Banks'
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
